Intervention

Platinum based chemotherapy

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting4

Common conditions9

Lead sponsors shown6

Clinical trials

6 shown

Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCNCT06623656 · 2025-02-21

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCNCT06216301 · 2024-07-31

A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLCNCT06424899 · 2024-05-19

A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)NCT05657873 · 2022-12-09

The Effect of Combined Cryotherapy and Immunotherapy on Systemic T Cell Changes and Clinical Outcomes in Metastatic Non-small Cell Lung CancerNCT06000358 · 2023-04-01

Gut Microbiota Reconstruction for NSCLC ImmunotherapyNCT05008861 · 2021-09-01

Common conditions

Non Small Cell Lung Cancer2 Carcinoma, Non-Small-Cell Lung1 Lung Cancer Stage IV1 Metastatic Non-small Cell Lung Cancer1 Non Small Cell Lung Cancer Metastatic1 Non-small Cell Carcinoma1 Non-Small Cell Lung Cancer1 NSCLC1 NSCLC Stage IV1

Leading sponsors

Lithuanian University of Health Sciences1 Memorial Sloan Kettering Cancer Center1 NovoCure GmbH1 Shanghai Zhongshan Hospital1 Weill Medical College of Cornell University1 Zeng Jian1

Trial status mix

RECRUITING4

UNKNOWN2

Phase mix

PHASE23

NA1

PHASE11

PHASE31

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.